granted
on 01 Oct 2024
Last Applicant/ Owned by
4 Orinda Way, Suite 100-D
Orinda
CA
94563
Serial Number
97270447 filed on 16th Feb 2022
Registration Number
N/A
Correspondent Address
Chang Sik Lim
Chang Sik Lim KNOBBE, MARTENS, OLSON & BEAR, LLP
KNOBBE, MARTENS, OLSON & BEAR, LLP
IRVINE, CA 92614
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; inform Read More
Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication
N/A
N/A
Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders; conducting educational seminars in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products and dissemination of materials in connection therewith; educational services, namely, conducting classes, seminars, conferences or workshops in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products
N/A
N/A
biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases
N/A
N/A
No 97270447
No Service Mark
No CGPH.019T
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
01st Oct 2024 | SOU EXTENSION 2 GRANTED |
01st Oct 2024 | SOU EXTENSION 2 FILED |
01st Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
01st Oct 2024 | SOU TEAS EXTENSION RECEIVED |
03rd Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
02th Apr 2024 | SOU EXTENSION 1 GRANTED |
02th Apr 2024 | SOU EXTENSION 1 FILED |
02th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
08th Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |